Q - Evolus,
For the period ended Jun 30, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 5, 2025
EOLS$6.81-2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows
(in thousands; Unaudited)
| Six Months EndedJune 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(36,034) | $(24,459) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,301 | 2,836 |
| Stock-based compensation | 10,416 | 10,863 |
| Provision for bad debts | 1,754 | 770 |
| Amortization of operating lease right-of-use assets | 572 | 301 |
| Amortization of debt discount and issuance costs | 610 | 559 |
| Deferred income taxes | 15 | 2 |
| Revaluation of contingent royalty obligation payable to Evolus Founders | (1,763) | 3,183 |
| Other adjustments to operating activities | 480 | — |
| Changes in operating assets and liabilities: | ||
| Inventories | (4,291) | 3,749 |
| Accounts receivable | (1,781) | (13,390) |
| Prepaid expenses | (1,443) | 193 |
| Accounts payable | 3,945 | (246) |
| Accrued expenses | (12,835) | (1,023) |
| Operating lease liabilities | (256) | (353) |
| Other operating assets | (3,113) | (70) |
| Net cash used in operating activities | (40,423) | (17,085) |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (1,007) | (721) |
| Additions to capitalized software | (3,121) | (1,330) |
| Net cash used in investing activities | (4,128) | (2,051) |
| Cash flows from financing activities | ||
| Payment of contingent royalty obligation to Evolus Founders | (4,416) | (3,607) |
| Proceeds from issuance and modification of debt instruments | 25,000 | — |
| Payments for debt modification fees and costs | (2,610) | — |
| Proceeds from follow-on offering | — | 51,211 |
| Payments for offering costs | — | (248) |
| Issuance of common stock in connection with incentive equity plan | 1,065 | 2,787 |
| Payment of financing lease obligation | (7) | — |
| Net cash provided by financing activities | 19,032 | 50,143 |
| Effect of exchange rates on cash and cash equivalents | 305 | (174) |
| Net increase (decrease) in cash and cash equivalents | (25,214) | 30,833 |
| Cash and cash equivalents, beginning of period | 86,952 | 62,838 |
| Cash and cash equivalents, end of period | $61,738 | $93,671 |
Condensed Consolidated Statements of Cash Flows (Continued)
(in thousands; Unaudited)
| Six Months EndedJune 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $7,786 | $8,838 |
| Cash paid for income taxes | 317 | 164 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.